pinocembrin has been researched along with Cancer of Ovary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Gao, J; Gao, Y; Lin, S; Wan, H; Zhu, H; Zhu, J; Zou, X | 1 |
1 other study(ies) available for pinocembrin and Cancer of Ovary
| Article | Year |
|---|---|
Pinocembrin inhibits the proliferation and migration and promotes the apoptosis of ovarian cancer cells through down-regulating the mRNA levels of N-cadherin and GABAB receptor.
Topics: Antineoplastic Agents; Apoptosis; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Female; Flavanones; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Receptors, GABA-B; RNA, Messenger | 2019 |